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Genome-wide association studies indicated the homeobox-containing transcription factor Engrailed-2 (En2) as a candidate gene for autism
spectrum disorders (ASD). Accordingly, En2 knock-out (En2/) mice show anatomical and behavioral “ASD-like” features, including de-
creased sociability and learning deficits. Themolecular pathways underlying these deficits inEn2/mice are not known.Deficits in signaling
pathways involvingneurofibrominandextracellular-regulatedkinase (ERK)havebeenassociatedwith impaired learning.Herewe investigated
the neurofibromin-ERK cascade in the hippocampus of wild-type (WT) and En2/ mice before and after spatial learning testing. When
compared with WT littermates, En2/mice showed impaired performance in the Morris water maze (MWM), which was accompanied by
lower expression of the activity-dependent geneArc. QuantitativeRT-PCR, immunoblotting, and immunohistochemistry experiments showed
amarked downregulation of neurofibromin expression in the dentate gyrus of both naive andMWM-treatedEn2/mice. ERKphosphoryla-
tion, known to be induced in the presence of neurofibromin deficiency, was increased in the dentate gyrus of En2/mice afterMWM. Treat-
ment of En2/mice with lovastatin, an indirect inhibitor of ERK phosphorylation, markedly reduced ERK phosphorylation in the dentate
gyrus,butwasunabletorescuelearningdeficits inMWM-trainedmutantmice.Furtherinvestigationisneededtounravelthecomplexmolecular
mechanisms linking dysregulation of neurofibromin-dependent pathways to spatial learning deficits in theEn2mousemodel of ASD.
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Introduction
Engrailed-2 (En2) is a homeodomain transcription factor in-
volved in regionalization and patterning of the midbrain/
hindbrain region (Joyner, 1996; Gherbassi and Simon, 2006).
Recent studies demonstrate that En2 is also widely expressed
in the postnatal brain and suggest that it might control the
structure and function of learning-related circuits (Tripathi et
al., 2009; Brielmaier et al., 2012; Sgado` et al., 2013a). Genetic
studies associated En2 to autism spectrum disorders (ASD;
Gharani et al., 2004; Benayed et al., 2009), and an abnormal
expression and methylation of the En2 gene was found in the
cerebellum of ASD patients (James et al., 2013). En2/ mice
display neuropathological changes related to ASD, including
cerebellar hypoplasia (Joyner et al., 1991; Kuemerle et al.,
1997) and loss of forebrain GABAergic interneurons (Tripathi
et al., 2009; Sgado` et al., 2013a). ASD-related behavioral defi-
cits, including increased seizure susceptibility (Tripathi et al.,
2009), reduced sociability, and impaired cognitive flexibility
(Cheh et al., 2006; Brielmaier et al., 2012) were also detected in
En2/ mice. Spatial learning and memory defects, such as
those detected in the Morris water maze (MWM), are espe-
cially robust in En2/ mice (Brielmaier et al., 2012) and
might be relevant to the cognitive impairments observed in
ASD patients (Dawson et al., 2002).
The cellular andmolecular underpinnings of impaired cogni-
tion in theEn2ASDmodel remain unknown.Deficits in signaling
pathways involving neurofibromin have been associatedwith im-
paired learning in neurodevelopmental disorders. Neurofibro-
min is the product of the NF1 gene, whose mutation causes
neurofibromatosis type 1, a complex genetic syndrome charac-
terized by nervous system tumors, behavioral and motor delays,
and cognitive disabilities (Gutmann et al., 2012). Neurofibromin
is a Ras-GTPase that negatively regulates Ras and its downstream
ERK (Fasano and Brambilla, 2011) and AKT/mTOR (Dasgupta
et al., 2005; Johannessen et al., 2005) pathways. Deficits in neu-
rofibromin signaling pathways have been associated with im-
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paired learning: mice with an Nf1
heterozygous null mutation showed en-
hanced phosphorylation of ERK, leading
to impaired long-term potentiation and
hippocampal-dependent learning (Cui et
al., 2008). Interestingly, these effects seem
to bemediated by loss ofNf1 in inhibitory
neurons (Cui et al., 2008), whose number
is markedly reduced in the hippocampus
of En2/ mice (Sgado` et al., 2013a). We
therefore investigated the neurofibromin/
ERK pathway in the hippocampus of WT
andEn2/mice following a spatial learn-
ing test in the MWM.
Materials andMethods
Animals. Experiments were conducted in con-
formity with the European Community Direc-
tive 2010/63/EU and were approved by the
Italian Ministry of Health. Animals were
housed in a 12 h light/dark cycle with food and
water available ad libitum. En2 mutants were
originally generated on a mixed 129Sv 
C57BL/6 genetic background (Joyner et al.,
1991) and then backcrossed at least five times
into a C57BL/6 background (Sgado` et al.,
2013a). Male and female WT and En2/ age-
matched adult littermates (3–5 months old;
weight 25–35 g) obtained from heterozygous
matings were used. A previous study showed
that learning abilities did not differ between
genders in both WT and En2/ mice (Briel-
maier et al., 2012). Fifty-two mice (26 per ge-
notype) were used in this study, divided in
three groups. The first group comprised 22
mice (11 per genotype) subjected to MWM.
Animals were killed at the end of MWM and
brains dissected. For RT-PCR and immuno-
blotting, four hippocampi per genotype were
dissected and frozen in dry ice; for immunohis-
tochemistry, four brains per genotype were fixed by 4% paraformalde-
hyde perfusion; and for in situ hybridization, three brains per genotype
were frozen on dry ice. The second group comprised 14 mice (7 per
genotype) treated with lovastatin and subjected to MWM. Brains from
these mice (n  4 per genotype) were fixed by 4% paraformaldehyde
perfusion at the end of MWM and used for immunohistochemistry. A
third group of naive mice (eight per genotype) was not subjected to
MWM and used as control. Their brains were dissected as described
above and used for RT-PCR/immunoblotting (four per genotype) and
immunohistochemistry (four per genotype).
Antibodies. Primary antibodies were as follows: rabbit polyclonal
anti-neurofibromin (Santa Cruz Biotechnologysc-67, 1:500 for immu-
noblotting; 1:100 for immunohistochemistry), mouse monoclonal anti-
-tubulin (-Tub; Santa Cruz Biotechnology sc-53140; 1:20,000), goat
polyclonal anti-En2 (Abcam ab45867; 1:250), rabbit polyclonal anti-
ERK1/2 (Santa Cruz Biotechnology sc-153; 1:2000), rabbit polyclonal
anti-phospho-ERK1/2 (Cell Signaling Technologies 4370, 1:1500 for
immunoblotting; 1:500 for immunohistochemistry), mouse mono-
clonal GAPDH (Santa Cruz Biotechnology sc-32233; 1:10,000), rabbit
polyclonal anti-GABA (Sigma; 1:2000), mouse monoclonal anti-
parvalbumin (PV; Sigma-Aldrich; 1:2000), rabbit polyclonal anti-
somatostatin (SOM; Peninsula-Bachem; 1:2000), and rabbit polyclonal
anti-neuropeptide Y (NPY; Peninsula-Bachem; 1:2000). Peroxidase-
conjugated, goat anti-rabbit or goat anti-mouse secondary antibodies
(Santa Cruz Biotechnology; 1:10,000–20,000) were used for immuno-
blotting. For immunohistochemistry, appropriate biotin-conjugated
secondary antibodies were incubated with streptavidin-conjugated fluo-
rophores (Alexa Fluor 488/594; Life Technologies) for immunofluores-
cence or avidin–biotin–peroxidase complex (ABC kit; Vector
Laboratories) for diaminobenzidine staining.
MWM. ImpairedMWMperformance is indicative of ASD-like cogni-
tive rigidity (Moy et al., 2006). Experiments were performed according to
van Praag et al. (1999). Mice were trained for 9 d (two trials a day) to
locate and escape onto a submerged platform in a circular tank (80 cm
diameter) filled with opaque water (22 1°C). For eachmouse, the start
position was pseudorandomized across trials, and the hidden platform
remained in the same quadrant for all trials across all training sessions. A
spatial probe trial was performed 4 h after the last trial on day 9 of
training; time spent, number of crossings, and proximity to platform in
all quadrants were scored (Maei et al., 2009). All animals were killed at
the end of the spatial probe trial session and brains dissected. Data were
acquired using EthoVision (Noldus Information Technology). To test
the effect of lovastatin on MWM performance, mice were given subcu-
taneous injections of 10 mg/kg lovastatin (Mevinolin; Sigma) for 3 d
before the first training day and then 6 h before training every day (Li et
al., 2005). Lovastatin solutionwas prepared as described previously (Li et
al., 2005).
In situ hybridization. In situ hybridization was performed as previously
described (Sgado` et al., 2013a) using an Arc-specific digoxigenin-labeled
riboprobe (nucleotides 358–1355 of the rat cDNA sequence NM_019361;
96% homologous to the mouse Arc sequence NM_018790.3). Digital im-
ages of three dorsal hippocampus sections per animal were analyzed
using ImageJ (http://rsb.info.nih.gov/ij/).ArcmRNA staining was calcu-
lated in a contour encompassing the CA1 and CA3 subfields, whereas
background staining was calculated in a contour placed over the corpus
Figure 1. En2/ mice show impaired spatial learning in the MWM test. A, Escape latency during training. B, Proximity to
platform in target andopposite quadrants duringprobe trial.C, Number of crossings in target andopposite quadrants duringprobe
trial. D, Time spent in target and opposite quadrants during probe trial. WT, Open circles; En2/, black squares; T, target
quadrant; OP, quadrant opposite to target. *p 0.05, **p 0.01, and ***p 0.001 (one-way ANOVA followed by Holm–Sidak
post hoc test; n 11 per genotype). E, Representative in situ hybridization onWT and En2/ hippocampi and quantification of
Arc mRNA signal in the CA1 and CA3 pyramidal cell layers (*p 0.05, **p 0.01; Student’s t test, WT vs En2/; n 3 per
genotype). Scale bar, 200m.
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callosum from the same section. Mean optical density values (normal-
ized to the contour area) were calculated by subtracting the aspecific
background to Arc-specific signal.
Quantitative RT-PCR and immunoblotting. Total RNAs and proteins
were extracted from dissected hippocampi using a protocol allowing
their simultaneous extraction from the same sample. Protocols were as
described previously (Dunleavy et al., 2013; Sgado` et al., 2013a; Allegra et
al., 2014). RT-PCR primers were as follows: NF1 forward 5-GGCT
GCTCATCAATATCATTC-3, reverse 5-AACTGGAACGGAAGGCA
ATG-3 (NM_010897.2); mouse mitochondrial ribosomal protein L41
(internal standard) forward 5-GGTTCTCCCTTTCTCCCTTG-3, re-
verse 5-GCACCCCGACTCTTAGTGAA-3 (NM_001031808.2). Im-
munoblots were revealed and quantified using
chemiluminescence followed by densitometry
using ImageJ;-Tub andGAPDHwere used as
internal standards.
Immunohistochemistry and cell counts. Im-
munohistochemistry was performed as de-
scribed previously (Sgado` et al., 2013a; Allegra
et al., 2014). To count neurofibromin-positive
cells, three to five sections at the level of the
dorsal hippocampus were analyzed per animal.
Multiple images from each section were ac-
quired at 20 objective magnification using a
Zeiss Observer Z1 microscope, and then as-
sembled using theMosaiX tool of the Zeiss Ax-
ioVision v4.8.1 software to reconstruct the
entire section. Light intensity and microscope
settings were optimized initially and then kept
constant to maintain the same exposure
through the single microphotographs and sec-
tions overall. Cell counts were then performed
on tiff-converted mosaic images using ImageJ
(http://rsb.info.nih.gov/ij/). Neurofibromin-
stained cells were counted in the hilus, granule
cell layer, and pyramidal cell layers over two to
three counting boxes of 100  100 m each.
Cell densities were expressed as the number of
labeled cells per counting window (100 100
m). To establish a consistent guideline for
counting individual cells, only cells larger than
5 mwith a clearly visible soma were counted.
Signals smaller than 5 m were excluded to
avoid counting neurites, nerve terminals, and
false signals.
To count pERK-positive cells, three to five
sections at the level of the dorsal hippocampus
were analyzed per animal.Multiple bright-field
images from each sectionwere acquired at 20
magnification using a Zeiss Axio Imager M2
microscope, and then assembled using Adobe
Photoshop. Cell counts were then performed
on tiff-converted mosaic images using ImageJ
(http://rsb.info.nih.gov/ij/). pERK-stained cells
were counted in the hilus, granule cell layer,
and pyramidal cell layers over two to three
counting boxes of 100  100 m each. Cell
densities were expressed as the number of la-
beled cells per counting window (100  100
m). For densitometric analysis of pERK
staining, acquired black and white images were
inverted. Two separate contours were drawn
for each digital image: positive stainingwas cal-
culated in the entiremossy fiber pathway (from
the hilus to the CA3 region), whereas back-
ground was calculated over the corpus callo-
sum. Mean optical density values (normalized
to the contour area) were calculated by sub-
tracting the nonspecific background to pERK-
specific signal in the mossy fibers. All counts and
measurementswere performedby an experimenter blind of genotypes.
Statistics. Statistical analyses were performed by GraphPad software.
Student’s t test or ANOVA followed by appropriate post hoc test was used,
with statistical significance level set at p 0.05.
Results
Spatial memory was assessed in 11WT and 11 mutant mice sub-
jected to MWM. Even if both genotypes showed significant de-
crease in escape latency to reach the hidden platformduring trials
(two-way repeated-measures ANOVA, main effect of training
Figure 2. Reduced neurofibromin expression in the En2/ hippocampus. A, Quantification of Nf1 mRNA expression in the
hippocampus of WT and En2/mice, before (naive) and after MWM. B, Representative neurofibromin (NF1) immunoblottings
from naive andMWM-trainedmice of both genotypes. Three samples per genotype and treatment group are shown. C, Represen-
tative immunostainings of the hilus from naive and MWM mice of both genotypes. Arrowhead indicates an example of
neurofibromin-positive neurons. D, Quantification of immunoblotting experiments (OD, optical density). E, Quantification of
neurofibromin-positive cells in the hilus. F–H, Densitometric analysis of neurofibromin immunostaining in the GCL (F ), CA3
pyramidal layer (G), andCA1pyramidal layer (H ). I, Countsofneurofibromin-positive cells in theCA1 stratumradiatum.*p0.05,
***p 0.001 (two-way ANOVA followed by Tukey’s post hoc test; n 4 per genotype per treatment group). Scale bar, 80m.
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day, F(8,197)  13.41, p  0.001), En2
/ mice reached the goal
less efficiently than WTmice (main effect of genotype, F(1,197)
17.15, p 0.001), starting from training day 3 (genotype train-
ing day interaction, F(8,197)  2.66, p  0.009; Fig. 1A). Similar
results were obtained for the path length (data not shown). Dur-
ing the probe trial, WT mice showed closer proximity to the
platform, as compared with En2/ mutants (Fig. 1B; one-way
ANOVA followed byHolm–Sidak post hoc test, *p 0.027, **p
0.007). Lack of quadrant selectivity in En2/ but not WT mice
was also detected in number of crossings (Fig. 1C), but not time
spent (Fig. 1D) in the target quadrant (one-way ANOVA fol-
lowed by Holm–Sidak post hoc test, *p  0.05, **p  0.01, and
***p  0.001). We then analyzed Arc mRNA levels in the hip-
pocampus after MWM to verify learning-induced gene expression.
In situ hybridization showed that Arc transcript was significantly
lower in CA1, CA3, and granule cell layer (GCL) of En2/ mice
comparedwithWT(Student’s t test,p0.0211 forCA1,p0.0044
forCA3;n 3 per genotype; Fig. 1E). These experiments extend the
notion that En2/ adult mice display marked deficits in a
hippocampal-dependent spatial learning task.
We next investigated neurofibromin expression in WT and
En2/mice before and after the MWM test. Real-time RT-PCR
experiments revealed significantly lower levels of Nf1 mRNA in
the hippocampus of En2/ naive mice compared with WT.Nf1
mRNA levels were significantly increased after MWM in both
genotypes, but remained lower in En2/ mice (two-way
ANOVA followed by Tukey’s post hoc test, p 0.05 for all com-
parisons; n 4 per genotype per treatment group; Fig. 2A). Im-
munoblotting confirmed that neurofibromin levels were lower in
the hippocampus of En2/ naive mice compared with WT.
MWM significantly increased neurofibromin in the WT but not
En2/ hippocampus, as compared with naive animals (two-way
ANOVA followed by Tukey’s post hoc test, p 0.05 for all com-
parisons; n  4 per genotype per treatment group; Fig. 2B,D).
Accordingly, immunohistochemistry experiments revealed a sig-
nificantly lower number of neurofibromin-positive neurons in
the hilus of En2/ naive mice compared with WT. A signifi-
cantly higher number of neurofibromin-positive hilar neurons
was present inWTmice followingMWMas comparedwith naive
animals, whereas this increase was not detected in the En2/
hilus (two-way ANOVA followed by Tukey’s post hoc test, p 
0.001 for all comparisons; n  4 per genotype per treatment
group; Fig. 2C,E). Intensity of neurofibromin staining in theGCL
and CA3/CA1 pyramidal layers (Fig. 2F–H) and number of
neurofibromin-positive cells in the stratum radiatum of the CA1
(Fig. 2I) did not differ across genotypes in both naive andMWM-
trained groups (two-way ANOVA followed by Tukey’s post hoc
test, p  0.05 for all comparisons; n  4 per genotype per
treatment group). Thus, in basal conditions, adult En2/ mice
display a marked reduction of neurofibromin levels in the hip-
pocampus, mainly due to a reduced number of neurofibromin-
positive neurons in the hilus. Most importantly, MWM testing
did not increase hippocampal neurofibromin protein levels in
En2/ mice, as instead observed in WT littermates. Impaired
neurofibromin-dependent pathways might therefore underlie
spatial learning deficits in En2/mice.
In the hilus, neurofibromin colocalized with En2 protein ex-
pressed in SOM and NPY but not PV interneurons (Fig. 3A).
Neurofibromin was widely expressed throughout the hippocam-
pus, whereas the phosphorylated form of the neurofibromin tar-
get ERKwasmainly restricted to the axonal compartment ofGCL
neurons (mf; Fig. 3B). Few scattered pERK-positive cells were
also detected in the GCL and other hippocampal subfields in
naive WT mice (Fig. 4A,B).
The reduced expression of neurofibromin suggests that pERK
might also be affected in theEn2/hippocampus. Immunoblot-
ting experiments showed that pERK and total ERK levels did not
differ across genotypes in the whole hippocampus of both naive
and MWM-trained mice (two-way ANOVA, p 0.05; Fig. 3C).
We then performed immunostainings to investigate ERK phos-
phorylation in hippocampal subfields of WT and En2/ mice
before and after MWM. pERK-positive neurons were scarcely
detected in the hilus of naive WT and En2/ mice, but clearly
visible in both genotypes followingMWM(Fig. 4A,B). Following
MWM, a significantly higher number of pERK-positive neurons
was present in hilus of En2/mice, as compared withWT (two-
way ANOVA followed by Tukey’s post hoc test, p  0.0001,
En2/MWM vsWTMWM; n 4 per genotype and treatment
group; Fig. 7A). Thus, neurofibromin deficiency results in in-
creased pERK in En2/ hilar neurons. A significantly higher
number of pERK-positive neurons was also detected in the GCL
of both WT and En2/ mice after MWM, as compared with
naive controls (two-way ANOVA followed by Tukey’s post hoc
test, p  0.001 for all comparisons; n  4 per genotype and
treatment group; Fig. 7B); following MWM, the number of
pERK-positive GCL neurons was significantly higher in En2/
mice compared withWT (two-way ANOVA followed by Tukey’s
Figure 3. Neurofibromin and pERK expression in the hippocampus. A, Representative double
immunostainings of neurofibromin (NF1; green) and En2, NPY, SOM, and PV (red) in the WT hilus.
Arrowheads indicate examples of NF1-positiveNPY and SOM interneurons.B, Double immunostain-
ingofNF1 (red) andpERK (green) in theWThippocampus.mf,mossy fibers. Scale bars:A, 50m;B,
250m. C, Left, Representative ERK1/2 and pERK1/2 immunoblottings on hippocampal extracts
from naive and MWM-trained WT and En2/ mice. GAPDH is used as internal standard. Right,
Quantification of immunoblotting experiments (n 4 per genotype); pERK levels were nor-
malized to total ERK. Normalization to GAPDH gave similar results (data not shown). Abbrevi-
ation: OD, optical density.
13284 • J. Neurosci., October 1, 2014 • 34(40):13281–13288 Provenzano et al. • NF1 Deficiency in En2/Mice
post hoc test, p  0.01, En2/MWM vs WT MWM; n  4 per
genotype and treatment group; Fig. 7B). Comparable pERK
staining was detected in the inner molecular layer (iml) of WT
and En2/ mice following MWM (Fig. 4B). Conversely, the
number of pERK-positive CA3 neurons was significantly in-
creased after MWM in both genotypes (two-way ANOVA fol-
lowed by Tukey’s post hoc test, p 0.001 for all comparisons; n
4 per genotype and treatment group; Figs. 4B, 7C). However,
following MWM, the number of pERK-positive CA3 neurons
was significantly lower in En2/mice compared withWT (two-
way ANOVA followed by Tukey’s post hoc test, p 0.05, En2/
MWMvsWTMWM; n 4 per genotype; Fig. 7C).MWMtesting
did not markedly alter pERK immunoreactivity in the mossy
fibers in both genotypes (Fig. 7D).
Previous studies showed that neurofibromin deficiency in
Nf1	/mice results in increasedpERK levels inGABAergic neurons
(Cui et al., 2008). Indeed, neurofibromin is expressed in NPY- and
SOM-positive GABAergic hilar interneurons (Fig. 3A). Thus, we
sought to determine which interneuron subtypes expressed neuro-
fibromin and pERK in WT and En2/ mice before and after
MWM. Double stainings for neurofibromin and GABA confirmed
that neurofibromin is expressed in hilar interneurons in both WT
and En2/ mice after MWM (Fig. 5). Neurofibromin-expressing
GABAergicneuronswere identifiedasSOM-andNPY-positive (Fig.
5) but notPV-positive (datanot shown) interneurons. Interestingly,
interneurons coexpressing neurofibromin and SOMwere less pres-
ent in MWM-trained En2/ mice, as compared with MWM-
trained WT controls (Fig. 5), whereas the number of interneurons
coexpressing neurofibromin and NPY was
comparable between these groups of ani-
mals (Fig. 5). Neurofibromin-positive neu-
rons did not express pERK in bothWT and
En2/ naive mice, while very few neurons
coexpressing neurofibromin and pERK were
detected in MWM-trained mice of both
genotypes (Fig. 5). Finally, pERKwasdetected
in hilar GABAergic interneurons, especially
inMWM-trained En2/mice (Fig. 5).
Systemic administration of lovastatin,
a specific inhibitor of HMG-CoA reduc-
tase (Kita et al., 1980), has been shown to
reduce ERK phosphorylation and rescue
learning deficits in Nf1	/mice (Li et al.,
2005). Since En2/mice show a 50% re-
duction in neurofibromin protein levels
(Fig. 2), we tested whether lovastatin treat-
ment was effective in restoring normal
pERK levels and rescuing learningdeficits in
MWM-trained En2/ mice. Lovastatin-
treated WT but not En2/ mice showed
decreased escape latency during training
(main effect of genotype, F(1,125)  22.36,
p 0.001;WT Lova vs En2/ Lova, n 7
per genotype; Fig. 6A), as well as quadrant
selectivity during the probe trial (Fig. 6B;
data not shown; one-wayANOVA followed
byHolm–Sidak post hoc test, *p 0.05,WT
Lova vs En2/ Lova, n 7 per genotype).
Thus, lovastatin treatment did not amelio-
rate spatial learning performance ofEn2/
mice (also compare lovastatin-treated
En2/ mice in Fig. 6A,B to untreated
En2/mice in Fig. 1A,C).
However, immunohistochemistry experiments showed a
comparable number of pERK-positive neurons in the hilus and
CA3 of lovastatin-treatedWT and En2/mice followingMWM
(Fig. 6C), indicating that lovastatin was indeed able to reduce
ERK phosphorylation in MWM-trained En2/ mice (compare
withFig. 4B). Quantification of pERK immunohistochemistry
experiments in naive, MWM, and MWM 	 Lova mice of both
genotypes confirmed these findings. Lovastatin significantly de-
creased the number of pERK-positive neurons in the hilus (Fig.
7A) and GCL (Fig. 7B) in MWM-trained En2/ mice, as com-
pared with MWM-trained En2/ mice that did not receive the
drug (two-way ANOVA followed by Tukey’s post hoc test; *p 
0.05, ****p0.0001; n 4 per genotype and treatment group).
In the CA3, lovastatin significantly decreased the number of
pERK-positive neurons in both genotypes, as compared with
MWM-trained mice that did not receive the drug (two-way
ANOVA followed by Tukey’s post hoc test; *p  0.05, ***p 
0.001; n  4 per genotype and treatment group; Fig. 7C). Lova-
statin decreased pERK staining in the mossy fibers only in WT
animals (two-way ANOVA followed by Tukey’s post hoc test; p
0.001, n 4 per genotype and treatment group; Fig. 7D).
Discussion
In this study,we showed that impaired spatial learning in theMWM
is associated with reduced neurofibromin expression and increased
pERK levels in the hilus of En2/ adult mice. These data lead us to
hypothesize that a marked dysregulation of neurofibromin/ERK
pathways in the hippocampus might contribute to learning deficits
Figure4. pERKstaining in thehippocampusofnaiveandMWM-trainedWTandEn2/mice.A, RepresentativepERK immunostain-
ings on whole dorsal hippocampi. B, Details of pERK immunostaining in the hilus and CA3 of the same mice as in A. White arrowhead
indicates a pERK-positive hilar neuron. Genotypes and treatments as indicated.mf,mossy fibers. Scale bars:A, 300m;B, 150m.
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in the En2 mouse model of ASD. To test this hypothesis, we used
lovastatin, an indirect inhibitor of ERK phosphorylation, to reduce
pERK levels and rescue learning deficits in of En2/ mice. While
being able to decrease ERK phosphorylation, lovastatin was unable
to rescue learning deficits inMWM-trainedmutant mice.
Spatial learningdeficitswerepreviously reported inEn2/ adult
mice (Chehet al., 2006;Brielmaier et al., 2012).Our results, obtained
on an independent colony of En2mice (though generated from the
same original En2tm1Alj strain, and maintained on a similar genetic
background; Sgado` et al., 2013a), are in good accordance with pre-
vious studies, thus confirming that spatial learning deficits are a spe-
cific behavioral trait of En2/ adult mice. As compared with WT
mice, En2mutants showed an increased latency to platform during
trials, and lack of quadrant selectivity in two of threemeasurements
(proximity score and platform crossing but not time spent in the
target quadrant) during the probe trial. Our results slightly differ
from those reported by Brielmaier et al. (2012), who showed signif-
icant differences betweenWTandEn2/mice also in time spent in
target quadrant. This might be explained by the slightly different
genetic background of the En2 colonies used in the two studies.
However, the proximity score is considered more sensitive for de-
tecting group differences than traditional measures (time spent and
number of crossings in the target quadrant; Maei et al., 2009). We
also extendedourbehavioral analysis to amolecular level, by looking
atArcmRNAexpression (extensively used as amolecular readout of
task-dependent hippocampal learning;Guzowski et al., 2001), dem-
onstrating that En2/mice display lowerArcmRNA levels follow-
ingMWM.
A first, novel finding of this study is the increase in
neurofibromin-positive hilar neurons in WT adult mice follow-
ing MWM. This suggests that neurofibromin-containing hilar
neurons and their circuits are profoundlymodified during learn-
ing, and theirmodificationmay contribute to long-termeffects of
behavioral training. Indeed, neurofibromin has been recently im-
plicated in inhibitory network rearrangements during working
memory (Shilyansky et al., 2010). Most importantly, we demon-
strate that En2/ adult mice have reduced levels of neurofibro-
min in the hippocampus. Neurofibromin is the product of the
Nf1 gene, whose heterozygous null mutation results in impaired
hippocampal-dependent learning (Silva et al., 1997; Costa et al.,
2002; Cui et al., 2008) and working memory deficits (Shilyansky
et al., 2010) in mice. We hypothesized that reduced Nf1 expres-
sion might contribute to spatial learning deficits observed in
En2/ mice. The molecular mechanisms through which En2
regulates Nf1 expression remain to be elucidated. In the hip-
pocampus, neurofibromin is coexpressedwith En2 (Fig. 3A), and
preliminary evidence from our laboratory indicates that the Nf1
gene promoter bears an En2 binding site, suggesting a direct tran-
scriptional control of En2 on Nf1 expression. In En2/ mice,
MWM increased neurofibromin mRNA but not protein levels
(Fig. 2), suggesting that an altered post-transcriptional control of
neurofibromin expression (Skuse and Cappione, 1997) may oc-
cur in mutant mice.
Studies performed onNf1	/mice indicate that learning def-
icits associated with partial loss of neurofibromin are mainly due
to altered Nf1 function in inhibitory neurons (Cui et al., 2008).
Indeed, neurofibromin is expressed in SOM and NPY hilar in-
terneurons (Fig. 3A) and partial loss of neurofibromin in the
En2/ hippocampusmainly occurs in the hilus (Fig. 2). Follow-
ingMWM, SOM-positive but notNPY-positive interneurons co-
expressing neurofibromin were less present in En2/ mice, as
compared with WT controls (Fig. 5), suggesting that altered
neurofibromin function mainly occurs in SOM-positive in-
terneurons inEn2/mice. Interestingly, these neurons and their
long-range connections to the entorhinal cortex have been re-
cently implicated in spatial learning (Melzer et al., 2012).
We previously showed a partial loss of hilar interneurons in
En2/ adult mice (Sgado` et al., 2013a). This explains why we ob-
served a lower number of neurofibromin-positive GABAergic in-
terneurons in the hilus of En2/mice, as comparedwithWTmice
(Figs. 2, 5), suggesting that loss of GABAergic inhibitory neurons
and reduced GABA signaling in the hilusmay also contribute to the
MWMlearning deficits observed inEn2/mice. This hypothesis is
in contrast with what was previously reported in Nf1	/ mice, in
which GABA receptor signaling is instead enhanced and treatment
with a GABA receptor inhibitor (picrotoxin) is sufficient to rescue
workingmemory deficits (Cui et al., 2008).
A possible explanation of our results might rely on the local-
ization of ERK phosphorylation in the hippocampus of WT and
En2/ mice before and after MWM. Immunoblotting experi-
ments revealed no difference in pERK levels between the two
genotypes; thismight be explained by the different levels of pERK
induction detected in different subfields of the En2/ hip-
pocampus before and after MWM (Figs. 4, 7). In agreement with
previous findings (Valjent et al., 2004), pERK staining inWT and
En2/ naive mice was mainly observed in the mossy fibers,
whereas pERK-positive neurons were barely detectable or totally
absent throughout other hippocampal regions. After MWM, a
general increase of pERK-positive neurons was observed in both
WT and En2/ mice, confirming that pERK upregulation is a
reliable marker of behavior-dependent anatomical plasticity.
Most importantly, a higher number of pERK-positive hilar neu-
rons was observed in En2/mice after MWM, confirming that
Figure 5. En2/ mice. Representative double immunostainings show the colocalization
ofneurofibromin (NF1; green) andpERK (green in the first andred inthesecondrowfrombottom)
in GABA-, NPY-, and SOM-positive hilar interneurons (all in red) in naive andMWM-trainedWT and
En2/mice.Usedantibodies, genotypes, and treatments areas indicated.White arrowheads indi-
cate examples of double-labeled neurons (yellow staining). Scale bar, 80m.
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neurofibromin deficits result in pERK induction. However,
the number of pERK-positive hilar interneurons coexpressing
neurofibromin was very low (Fig. 5), and a higher number of
pERK-positive neurons was also detected in the GCL of MWM
En2/mice, where neurofibromin downregulation was not de-
tected (Fig. 2C,F). Moreover, the increase
of pERK-positive neurons following
MWMwas less evident in En2/mice in
the CA3 (where neurofibromin expres-
sion did not differ between WT and
En2/ mice; Fig. 7C). Thus, neurofi-
bromin-dependent pathways different
from the RAS/ERK cascade might under-
lie hippocampal-dependent learning def-
icits observed in En2 mutants. In this
animalmodel, loss of GABAergic neurons
might be one of the key factors underly-
ing spatial learning impairment. Indeed,
recent findings demonstrate that optoge-
netic inhibition of hilar GABAergic in-
terneuron activity is able to impair spatial
learning andmemory retrieval (Andrews-
Zwilling et al., 2012).
In the recent years, several mouse
models of ASD have been characterized,
with themajor aim to identify novel phar-
macological targets, and encouraging
results have been obtained in some in-
stances (Silverman et al., 2010; Han et al.,
2012, 2014; Provenzano et al., 2012; Delo-
rme et al., 2013). Here we described for
the first time that reduced neurofibromin
expression and deregulated ERK phos-
phorylation are associated with impaired
learning in the En2 model of ASD. How-
ever, pharmacological inhibition of ERK
activity by lovastatin treatment was not
able to reverse learning deficits in En2/
mice, as instead previously shown in
Nf1	/mice (Li et al., 2005).
The question of whether we can rescue
learning deficits in En2/ mice remains
open. As discussed above, our results sug-
gest that neurofibromin-dependent path-
ways different from the RAS/ERK cascade
might be involved in hippocampal-de-
pendent learning impairment observed in
En2 mutants. Indeed, neurofibromin is
known also to regulate the mTOR path-
way (Dasgupta et al., 2005; Johannessen et
al., 2005), which has been found to be de-
regulated inmousemodels of neurodevel-
opmental disorders (Ricciardi et al., 2011;
Tsai et al., 2012). Moreover, our recent
transcriptome study indicates that several
signaling pathways, different from those
involving ERK phosphorylation, are de-
regulated in the hippocampus of adult
En2/mice (Sgado` et al., 2013b). Finally,
a recent study showed that treatment with
a noradrenergic agonist did not com-
pletely rescue learning and memory defi-
cits in En2/ mice (Brielmaier et al.,
2014), suggesting that cognitive learning is hardly restored after
pharmacological treatment in thesemutants. Thus, further inves-
tigation is needed to unravel the complexmolecular mechanisms
linking dysregulation of the neurofibromin pathway to spatial
learning deficits in the En2mouse model of ASD.
Figure 6. Lovastatin rescues ERK phosphorylation but not spatial learning performance in MWM-trained En2/ mice.
Lovastatin-treated WT and En2/ mice were subjected to MWM. Escape latency during training and number of platform
crossings in target and opposite quadrants during probe trial are shown in A and B, respectively. Lova, Lovastatin; lovastatin-
treated WT, open circles; lovastatin-treated En2/, black squares; T, target quadrant; OP, quadrant opposite to target. *p
0.05; ***p 0.001 (one-way ANOVA followed by Holm–Sidak post hoc test; n 7 per genotype). C, Representative pERK
immunostainings in the hilus and CA3 of lovastatin-treatedWT and En2/mice subjected to MWM. Genotypes and treatments
as indicated. Scale bar, 150m.
Figure 7. Quantification of lovastatin effect on ERK phosphorylation in the hippocampus of MWM-trained WT and En2/
mice. Graphs show the quantification of pERK staining in different hippocampal subfields of lovastatin-treated, MWM-trained
(MWM	 Lova)WT and En2/mice, as comparedwith untreatedWT and En2/mice, before (naive) and after (MWM)MWM
training (Fig. 4 for representative pERK immunostainings from naive and MWM-trained WT and En2/mice). A–C, Counts of
pERK-positive neurons in the hilus (A), GCL (B), and CA3 (C).D, pERK staining in themossy fibers. *p 0.05, **p 0.01, ***p
0.001, and ****p 0.0001 (two-way ANOVA followed by Tukey’s post hoc test; n 4 per genotype and treatment group).
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